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Loricrin is a major constituent of the epidermal cor-
ni®ed cell envelope. We have recently identi®ed het-
erozygous loricrin gene mutations in two
dominantly inherited skin diseases, the ichthyotic
variant of Vohwinkel syndrome and progressive
symmetric erythrokeratoderma, collectively termed
loricrin keratoderma. In order to see whether the
mutant loricrin molecules predicted by DNA
sequencing are expressed in vivo and to de®ne their
pathologic effects, we raised antibodies against syn-
thetic peptides corresponding to the mutated
sequences of loricrin. Immunoblotting of horny cell
extracts from loricrin keratoderma patients showed
speci®c bands for mutant loricrin. Immunohisto-
chemistry of loricrin keratoderma skin biopsies
showed positive immunoreactivity to the mutant
loricrin antibodies in the nuclei of differentiated
epidermal keratinocytes. The immunostaining was
localized to the nucleoli of the lower granular cell
layer. As keratinocyte differentiation progressed the
immunoreactivity moved gradually into the nucleo-
plasm leaving nucleoli mostly nonimmunoreactive.
No substantial staining was observed along the corni-
®ed cell envelope. This study con®rmed that mutant
loricrin was expressed in the loricrin keratoderma
skin. Mutant loricrin, as a dominant negative disrup-
ter, is not likely to affect corni®ed cell envelope
crosslinking directly, but seems to interfere with
nuclear/nucleolar functions of differentiating kerati-
nocytes. In addition, detection of the mutant loricrin
in scraped horny layer could provide a simple nonin-
vasive screening test for loricrin keratoderma. Key
words: nuclear localization signals/nucleolus/palmoplantar
keratoderma/progressive symmetric erythrokeratoderma/
Vohwinkel syndrome. J Invest Dermatol 115:1088±1094,
2000
T
he corni®ed cell envelope (CE) is a covalently
crosslinked layer of protein that is formed by
epidermal keratinocytes in a late stage of differentia-
tion (Ishida-Yamamoto and Iizuka, 1998). Loricrin is
a small basic protein synthesized in the upper
granular layer and becomes a major constituent of the CE (Mehrel
et al, 1990; Hohl et al, 1991; Yoneda et al, 1992; Ishida-Yamamoto
et al, 1998a). Heterozygous mutations in the loricrin gene have
been detected in two forms of dominantly inherited skin diseases,
the ichthyotic variant of Vohwinkel syndrome (IVS) and a unique
variant of progressive symmetric erythrokeratoderma (PSEK)
(Maestrini et al, 1996; Ishida-Yamamoto et al, 1997; Korge et al,
1997; Armstrong et al, 1998; Takahashi et al, 1999). These disorders
have been collectively termed loricrin keratoderma (LK) (Ishida-
Yamamoto and Iizuka, 1998; Ishida-Yamamoto et al, 1998a). The
mutations found in LK are very similar in that they are insertions of
a single nucleotide resulting in a frameshift and a delayed
termination codon. The patients also share clinical features:
mutilating palmoplantar hyperkeratosis with a honeycomb appear-
ance and formation of digital constriction bands (pseudoainhum).
Other clinical manifestations entail mild ichthyosis in IVS and
generalized erythematous keratotic plaques in PSEK.
Although the gene defects underlying LK have been identi®ed,
the mechanism by which the mutant loricrin causes keratoderma
remains unknown. As the corni®ed cells of the patients showed
some characteristics of transitional cells (Ishida-Yamamoto et al,
1998b), we speculated that the differentiation of keratinocytes from
the granular to the corni®ed cells is speci®cally disrupted at the
transitional cell level. In the LK skin, loricrin was distributed
aberrantly when it was stained with antibodies against the N-
terminus of loricrin (Maestrini et al, 1996; Ishida-Yamamoto et al,
1997; Korge et al, 1997). Nuclear staining was stronger with the N-
terminal loricrin antibody compared with the C-terminal antibody,
suggesting that the mutant loricrin, which cannot be recognized by
the C-terminal antibody, was preferentially localized within the
nuclei in LK (Korge et al, 1997). In order to determine where the
mutant loricrin is expressed in LK skin, we raised antibodies against
the predicted C-terminal sequences that are common to all known
loricrin mutants, which could be analyzed by immunohistochem-
istry. We found that the mutant loricrin was indeed expressed in
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LK skin and that its localization was almost exclusively in the
nucleus rather than the CE. This suggests that mutant loricrin
deranges keratinocyte terminal differentiation not by direct
disruption of CE assembly but by affecting nuclear function.
MATERIALS AND METHODS
Samples Normal human skin from the neck and the thigh was obtained
at the time of plastic surgery. Biopsies from lesional skin of two patients
with PSEK and a patient with IVS, and lesional and nonlesional skin of
another patient with IVS, were taken after obtaining informed consent.
Heterozygous insertion mutations of the loricrin gene have been identi®ed
in these patients, a C insertion at codons 224±225 in PSEK and a T
insertion at codon 209 and a G insertion at codons 230±231 in IVS (Ishida-
Yamamoto et al, 1997; Korge et al, 1997; Armstrong et al, 1998). Horny
layers of four LK patients (two with PSEK and two with IVS) were also
collected by scraping the sole or arm with a razor blade.
Production of mutant loricrin antibody C-terminal 18 amino acids
of mutant loricrin plus cystein at the N-terminus (Cys-Pro-Gly-Tyr-Gly-
Gly-Glu-Gly-Val-Gly-Gly-Val-Phe-Gln-Gly-His-Arg-Trp-Ala) was
synthesized (CS Bio, San Carlos, CA). This peptide was covalently
coupled to keyhole limpet hemocyanin (Pierce Chemical, Rockford, IL)
through the sulfhydryl group of the N-terminal cystein with the
bifunctional crosslinker m-maleimidobenzoyl-N-hydroxysuccinimide
ester (Boehringer-Mannheim, Tokyo, Japan) and used to immunize
rabbits. Sera with high enzyme-linked immunosorbent assay (ELISA)
titer to the mutant loricrin peptide were obtained from two rabbits
(mlo1, mlo2).
Immunoblot analysis Scraped stratum corneum cells from four LK
patients and a normal human subject were ®xed with 10% trichloroacetic
acid in phosphate-buffered saline (PBS) pH 7.4 for 30 min on ice and
centrifuged at 1000 rpm for 5 min at 4°C. This pellet was sonicated and
extracted in 9 mol per l urea, 2% Triton X-100, 1% dithiothreitol/Tris
buffer. Five milligrams of total protein was loaded on a lane of 12.5%
sodium dodecyl sulfate polyacrylamide slab gels 1 mm thick and subjected
to electrophoresis as described by Laemmli (1970). After electrophoresis,
gel slabs containing separated proteins were electrophoretically transferred
to polyvinylidene di¯uoride membrane (Immobilon-p, Nihon Millipore,
Tokyo, Japan) in transfer buffer containing 25 mM Tris and 192 mM
glycine. Non-speci®c binding sites were blocked by immersing the
membranes in 5% skim milk in Tris-HCl buffered saline (TBS) pH 7.6 for
1 h at room temperature. After rinsing in TBS, the membrane was
incubated with mlo antisera (mlo1 and mlo2, both in 1:8000 dilution in
TBS) or with antibody against C-terminus of normal loricrin (AF62,
Berkeley Antibody, Richmond, CA; 1:4000 dilution in TBS) overnight at
4°C. After rinsing in TBS, the membrane was incubated with horseradish
peroxidase linked F(ab¢)2 fragment against rabbit Ig from donkey
(Amersham, Buckinghamshire, U.K.; 1:5000 dilution in TBS).
ECL+Plus Western blotting detection system (Amersham) was used for
immunodetection. For a competition analysis, the diluted primary
antibodies were reacted with the synthetic mutant loricrin peptide
(5 mM) for 1 h at 37°C. Molecular weight markers were phosphorylase b
(94,000), bovine serum albumin (67,000), ovalbumin (43,000), carbonic
anhydrase (30,000) and soybean trypsin inhibitor (20,100). The
experiments were performed in duplicate, each time essentially with the
same results.
Immuno¯uorescence Immuno¯uorescence studies on semithin
sections of Lowicryl-embedded skin (see below) and cryostat sections of
the scraped skin were incubated with mlo antisera (mlo1 and mlo2, both in
1:100 dilution in PBS) or with antibody against C-terminus of normal
loricrin (AF62, 1:500 dilution in PBS) for 30 min at 37°C. This was
followed by incubation with ¯uorescein isothiocyanate (FITC) conjugated
swine antirabbit IgG antibodies (DAKO, Glostrup, Denmark) after dilution
(1:20) in PBS for 30 min at 37°C. For peptide competition, the diluted mlo
antisera were preincubated with 5 mM peptide for 1 h at 37°C and then
used for immuno¯uorescence. Nuclei were stained with propidium iodide.
For double staining with a nucleolar antigen, cryostat skin biopsy
sections were incubated with a mixture of mlo antisera and a mouse
monoclonal antibody, AE-3, that recognizes a human nucleolar antigen
(Leinco Technologies, Ballwin, MO; with no dilution) for 30 min at 37°C.
This was followed by incubation with a mixture of FITC-conjugated swine
antirabbit Ig (DAKO) and Texas-Red-conjugated sheep antimouse Ig (1:10
dilution, Amersham). Nuclei were stained with 4¢,6-diamidino-2-phenyl-
indole dihydrochloride (DAPI, Nacalai Tesque, Kyoto, Japan).
Fluorescence immunolabeling was observed using an Olympus BX-FLA-
1 system (Tokyo, Japan). Analog images were taken using a 35 mm
Fujichrome Provia400 ®lm (Fuji, Tokyo, Japan). Digital images were
captured using an electric-cooled CCD camera (SenSys, Photometrics,
Tucson, AZ). The camera and image processing were controlled using IP
Lab Spectrum software (Sigma Analytics, Vienna, VA).
Electron microscopy and immunoelectron microscopy Trans-
mission electron microscopy was performed as described elsewhere
(Ishida-Yamamoto et al, 1997; Korge et al, 1997). For immunoelectron
microscopy, skin tissue samples were cryo®xed, cryosubstituted, and
embedded in Lowicryl K11M resin (Chemische Werke Lowi,
Waldkraiburg, Germany) according to the methods previously described
(Shimizu et al, 1989; Ishida-Yamamoto et al, 1996). Ultrathin sections were
cut, collected on Formvar-coated nickel grids, and immunostained as
described previously (Ishida-Yamamoto et al, 1996). As the primary
antibodies mlo antisera (mlo1 and mlo2, both in 1:200 dilution), anti-
loricrin antibody (AF62, 1:500 dilution) and anti-involucrin mouse
monoclonal antibodies (SY5, kindly provided by Dr. F.M. Watt, 1:100
dilution) were used. As labels, 10 nm gold-conjugated goat antirabbit IgG
and 5 nm gold-conjugated goat antimouse IgG (Amersham, 1:10 dilution)
were used. To retrieve masked epitopes, ultrathin sections were incubated
prior to immunostaining with 0.4 mg per ml proteinase K in 50 mM Tris-
HCl (pH 7.4) at room temperature for 30 s to 5 min. For contrast, the
sections were stained with uranyl acetate. For all immunohistochemistry,
negative controls included incubation in the presence of a secondary
antibody alone, and incubation with unrelated primary antibodies.
RESULTS
Mutant loricrin was detected in the LK skin Two antibodies
against the mutant loricrin peptide, mlo1 and mlo2, gave essentially
the same results. Immunoblots of horny cell extracts from two
PSEK patients showed a band of 39 kDa, but no band was detected
in control samples (Fig 1). Higher molecular weight bands of about
Figure 1. Immunoblot detects mutant loricrin. Positive bands are
detected in LK horny cells (lanes 2 and 3), but not in normal control (lane
1). Extracts from scraped horny cells were fractionated on 12.5% sodium
dodecyl sulfate polyacrylamide gels and immunoblotted with the mlo2
antibody preincubated with 5 mM mutant loricrin peptide in TBS (lane 3)
or with TBS (lanes 1 and 2) for 1 h at 37°C. The sizes of molecular weight
standards are shown on the left. The square denotes the approximately 39
kDa mutant loricrin protein and circles are for its possible polymers.
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80 and 120 kDa were also detected in the patient samples. The
intensity of these bands was greatly decreased when the mlo
antibodies were preincubated with mutant loricrin peptides. We
did not detect apparent difference in the amount of expressed
mutant loricrin proteins between the horny layer samples from two
PSEK patients and from two IVS patients (not shown). No band
was detected for the antibody against normal C-terminus of loricrin
(not shown).
Lesional skin from the four LK patients showed identical
immunostaining patterns (Fig 2). Positive reaction was detected
almost exclusively within the nuclei of differentiated epidermal
keratinocytes. In a higher magni®cation immunoreactivity was
found to be associated with distinct globular structures in the lower
granular cell layers, and large areas of nucleoplasm became
immunoreactive in the super®cial granular cell layers and
parakeratotic corni®ed cell layers. This staining was abolished by
preincubating the mlo antibodies with the mutant loricrin peptide.
The antibodies also stained parakeratotic nuclei of the scraped
horny layer of LK skin. Positive reaction was also obtained in the
nuclei of upper granular cells and corni®ed cells from nonlesional
skin of an LK patient. Normal control skin did not show
immunoreactivity. The antibody against C-terminus of wild-type
loricrin showed positive reactions in the cytoplasm as well as in the
nucleus in the granular cells of both normal and LK epidermis.
Double staining with a nucleolar antibody revealed that the mutant
loricrin positive globular structures in the lower granular cells were
nucleolus (Fig 3).
Mutant loricrin was associated with nucleolus To correlate
immunohistochemical ®ndings with morphologic events in the
nuclei and to de®ne localization of mutant loricrin at an
ultrastructural level, transmission electron microscopy and
Figure 2. Mutant loricrin is expressed within
the nuclei of LK keratinocytes. Mutant (a-f )
and wild-type loricrin ( g) staining. Lesional skin
(a-c, g), scraped sole skin horny layer (d ), and
nonlesional skin (e) from LK patients, and normal
control skin ( f ). (a) Green ¯uorescence for
mutant loricrin is detected within the differen-
tiated keratinocyte nuclei. (b) Mutant loricrin is
associated with globular intranuclear structures in
the lower granular cells (arrowheads). (c) Preincuba-
tion of the antibody with mutant loricrin peptide
abolishes immunoreaction. (d ) Punctate staining in
the scraped horny layer of LK sole skin. (e) The
most super®cial granular cells in the nonlesional
skin also express mutant loricrin. ( f ) No reaction
is detected in normal skin. ( g) Normal loricrin is
expressed in the cytoplasm as well as in the
nucleus. Scale bars: 10 mm.
Figure 3. Mutant loricrin is accumulated on
nucleolus. Cryostat sections of an LK patient
were double stained for mutant loricrin antibody
(green) and a nucleolar antigen (red). Nuclei are
also stained with DAPI (blue). Merged ®gures of
mutant loricrin and DAPI (a), a nucleolar antigen
and DAPI (b), and all three staining (c). Arrows in-
dicate mutant loricrin-positive nucleoli. Scale
bar: 10 mm.
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postembedding immunoelectron microscopy were performed. In
both normal and LK epidermis, nuclei in the basal, spinous, and
lower granular cells were with little heterochromatin and active
large reticulate nucleoli that contained several ®brillar centers
surrounded by a dense ®brillar component and granular component
(Fig 4). Nuclei in the upper granular cells had increased
heterochromatin and a small nonactive nucleolus with a few
®brillar centers. Electron-dense granular deposit in the nucleoplasm
and within the nucleoli of the middle to upper granular cells was
unique to LK skin. In the lesional skin, mlo staining was detected
within the nuclei from the lower granular cells through the
corni®ed cells (Fig 5). It was speci®cally on the granular
component and dense ®brillar component of active nucleolus in
the lower granular cells. In the middle granular cells,
immunopositive deposit appeared around the nucleolus and also
in the nucleoplasm. In the super®cial granular cells, most of the
labels were in the nucleoplasm, whereas nucleolus became mostly
nonimmunoreactive. In the nonlesional skin, the uppermost
granular cells contained immunoreactive deposit in the
nucleoplasm. Nucleoli were usually inactive ones with some
positive immunoreaction. Anti-normal loricrin antibodies stained
the granular cell cytoplasm and nuclei diffusely. They were not
particularly associated with nucleoli in the normal skin nor in the
LK skin.
Normal loricrin epitopes on CE were masked The CE in
the corni®ed cells of the LK patients was strongly positive to
involucrin antibodies, but showed very little labeling for normal or
mutant loricrin (Fig 6). As immature CE or cell membrane of the
uppermost LK granular cells was relatively well labeled with
antibodies against normal loricrin (Korge et al, 1997), we tested
whether the decreased loricrin labeling in the CE of corni®ed layer
was due to epitope masking. To retrieve possible masked epitopes,
we performed immunoelectron microscopy on protease-treated
sections (Matsuki et al, 1998). Loricrin labeling on the CE of LK
corni®ed cells was greatly enhanced by protease K digestion (for
30 s to 5 min). CE remained nonimmunoreactive to mlo antibodies
after this treatment (not shown).
DISCUSSION
So far three types of loricrin mutations have been detected in
genomic DNA from ®ve LK families (Maestrini et al, 1996; Ishida-
Yamamoto et al, 1997; Korge et al, 1997; Armstrong et al, 1998;
Takahashi et al, 1999). All three mutations are heterozygous
insertion mutations of a single nucleotide that result in a frameshift
and a common downstream delayed termination codon.
In this study, we raised antibodies against mutant loricrin.
Immunoblotting showed that the antibodies were speci®c and
con®rmed that mutant loricrin molecules were actually present in
LK horny cells. The detected bands were of 39 kDa, larger than the
molecular weight of 32 kDa calculated from mutant loricrin
sequences (a C insertion at codons 224±225). Immunoblotting of
normal loricrin also showed higher bands (32 kDa) than the
calculated molecular weight (26 kDa) (Hohl et al, 1993, and our
own observation, not shown). These phenomena might be due to
the sequences rich in hydrophobic amino acids in both normal and
mutant loricrin. Alternatively, there might be unknown post-
translational modi®cation of loricrin that increases molecular
weight. The higher bands of 80 and 120 kDa might be polymers
of mutant loricrin crosslinked by transglutaminases.
Immunohistochemisty further demonstrated that mutant loricrin
was expressed in the LK epidermis. The staining patterns were
identical between the two IVS patients and two PSEK patients.
The staining was localized in the differentiated keratinocytes in a
predicted tissue- and differentiation-dependent manner and was
detected up to the corni®ed layer. Our results suggest that detection
of the mutant loricrin in scraped horny layer by immunoblotting or
immunohistochemistry might offer simple noninvasive screening
tests for LK. We have recently tested a different family with PPK
Figure 4. Electron-dense nuclear granules ap-
pear around an inactive nucleolus in the dif-
ferentiated LK keratinocytes. Transmission
electron microscopy of normal (a, c) and LK (b, d)
epidermis. (a, b) Active large reticulate nucleoli in
the lower granular cells contain several ®brillar
centers (c) surrounded by dense ®brillar compo-
nent (d) and granular component (g). (c, d) Nuclei
in upper granular cells have a nonactive small nu-
cleolus. Electron-dense nuclear granules are un-
ique to LK skin (d, arrowheads). Each nucleolus is
shown in a lower magni®cation as an inset. ch,
chromatin. Scale bar: 0.5 mm; 5 mm in insets.
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with these antibodies and obtained positive results. Subsequent
DNA sequencing detected an insertion mutation of a single
nucleotide in the loricrin gene (unpublished).
As for the pathomechanisms of dominantly inherited disorders,
some are explained as dominant negative effects of mutant
molecules and others are attributed to haploinsuf®ciency.
Although loricrin constitutes about 70% of CE in normal skin
(Steven and Steinert, 1994; Steinert, 1995), the phenotype of
loricrin null mice was just temporary and lasted only 4±5 d after
birth.1 This suggests that LK is not caused by haploinsuf®ciency of
loricrin but by some dominant negative effects of the mutant
loricrin. The nature of these dominant negative effects remains
unknown. We previously raised the possibility that the mutant
loricrin disrupts assembly of CE (Maestrini et al, 1996; Ishida-
Yamamoto et al, 1997; Armstrong et al, 1998). Because of the
frameshift mutations, mutant molecules lack the C-terminal
glutamine-lysine rich domain essential for crosslinking. CE of the
LK corni®ed cells was immunoreactive to involucrin antibodies,
but showed very little immunoreactivity to loricrin antibodies
(Maestrini et al, 1996; Ishida-Yamamoto et al, 1997; Korge et al,
1997). This is contrary to the normal CE that was positive to
loricrin but negative to involucrin (Ishida-Yamamoto et al, 1996).
Wild-type loricrin was detected along the CE in the granular cells
of LK, however, and loricrin epitopes on the CE of corni®ed cells
were retrieved by protease digestion of the sections. Therefore, it is
more likely that normal loricrin is crosslinked into CE of LK, but its
epitopes are masked by extensive further crosslinking with other
molecules such as involucrin. Involucrin is one of the early
constituents of CE (Eckert et al, 1993; Robinson et al, 1996;
Steinert and Marekov, 1997) with their epitopes normally masked
when the CE is matured by later crosslinking of loricrin and other
molecules (Ishida-Yamamoto et al, 1996). By contrast, involucrin
crosslinking seems to continue after loricrin is crosslinked and mask
loricrin epitopes in LK.
Because mutant loricrin was expressed within the nuclei and not
associated with cell membranes or CE, it is unlikely that the mutant
loricrin is crosslinked into CE directly interfering with its
formation. Instead, it is plausible to speculate that mutant loricrin
deranges keratinocyte terminal differentiation by some other
mechanisms. Nuclear localization of mutant loricrin suggests that
it exerts dominant negative effects through interactions with
nuclear proteins and/or nucleic acids. Interestingly arginine-rich
sequences of mutant loricrin show homology to a highly basic
nuclear protein, protamines (43% identity at the amino acid level
with sperm protamine SP1) (Willmitzer and Wagner, 1980;
Wouters-Tyrou et al, 1998). It is known that protamines interact
with DNA on their arginine clusters. Alternatively initial associa-
tion with nucleoli might indicate a pathologic role of the mutant
loricrin upon nucleolar functions.
In the LK epidermis, nucleoli from the basal to the lower
granular layer were not apparently different from those in normal
skin, but those in the upper layer were distinct. There was
deposition of mutant loricrin within and around the nucleoli.
Localization of mutant loricrin in the dense ®brillar component and
granular component of the cells with a high level of ribosomal
biosynthesis suggests interaction between mutant loricrin and
Figure 5. Mutant loricrin is associated with
an active nucleolus. Immunoelectron micro-
scopy of mutant (a, b) and wild-type (c) loricrin in
LK epidermis. Nucleoli (arrows) in lower granular
cells (a, c) and an upper granular cell (b). (a)
Mutant loricrin is associated with dense ®brillar
component (d ) and granular component ( g) of an
active nucleolus. Fibrillar centers (c) are not
labeled. (b) Mutant loricrin is on the periphery of
an inactive nucleolus and in the nucleoplasm
(arrowheads). (c) Wild-type loricrin is distributed
diffusely, not particularly associating with nucleoli.
Scale bar: 0.1 mm.
1de Viragh PA, SchaÈten L, Bundman D, Roop DR: Transient congenital
erythroderma in loricrin de®cient mice. J Invest Dermatol 107:448, 1996
(abstr.)
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rRNA or rRNA binding proteins. Recent evidence also suggests
that nucleolus is a preferred intracellular target for apoptotic events
(Stegh et al, 1998). Terminal differentiation of keratinocytes is a
typical example of programmed cell death (Ishida-Yamamoto et al,
1998b). Mutant loricrin might derange the keratinocyte differ-
entiation/cell death pathway by affecting nucleolus as a target of
apoptotic cellular changes. This might explain delay of the cell
death process in LK epidermis in the stage where nuclear DNA is
fragmented (Ishida-Yamamoto et al, 1998b). Alternatively mutant
loricrin might disturb other functions of nucleolus that include
nonribosomal RNA processing and growth factor signal transduc-
tion (Pederson, 1998a; 1998b).
The reason for limited distribution of skin lesions in LK patients
despite the generalized expression of the mutant loricrin is obscure
at this moment. In the nonlesional skin mutant loricrin-expressing
cells were just one cell layer thick and were to cornify in the next
cell layer. It might be that, if mutant loricrin is expressed in a very
late stage of terminal differentiation where nucleolus is no more
active, the mutant loricrin does not hamper the completion of
differentiation. In the palmoplantar skin loricrin-expressing cells are
several layers thick. When the cells start to express mutant loricrin,
they still have a long way to go with late keratinization processes
that are more likely to be affected. It remains to be explained why
the extra-palmoplantar lesions vary in PSEK and IVS as well.
Small proteins with molecular mass less than 40±60 kDa can cross
the nuclear pore complex by diffusion (Nigg, 1997). Loricrin is a
small molecule (26 kDa in human and 38 kDa in mouse) and
localized in both the cytoplasm and nucleoplasm (Steven et al,
1990; Ishida-Yamamoto et al, 1996, 1998a). The mechanisms for
nuclear translocation and speci®c association with nucleolus of
mutant loricrin remain unknown at present. The sequences of
mutant loricrin rich in arginine might function as consensus
bipartite nuclear localization signals (Korge et al, 1997). The
nucleolar protein localization system is not well understood and it
has been suggested that a common motif to some nucleolar
targeting sequences is short highly basic segments rich in arginine or
lysine. A peptapeptide (RRQRR), which has been implicated as
part of a nucleolar targeting element in signal recognition
particles (Pederson, 1998b), is present in the mutant loricrin and
this might be functional. These possibilities have to be tested in
future studies.
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